Market Research Industry Reports

Medical Affairs Reputations (EU5) [CLL]


How well does your CLL medical affairs team performance compare with the rest?

Is ‘moderately satisfied’ good enough? According to this latest survey of 150 medical oncologists and haematologists across the EU5 (UK, France, Germany, Italy and Spain) the performance of chronic lymphocytic leukaemia medical affairs teams still has a way to go in some key areas before higher satisfaction ratings can be achieved across the board. Find out what physicians think is done well; what they want to see more of; and why some are dissatisfied.

Use Medical Affairs Reputations: Chronic Lymphocytic Leukaemia 2017 (EU5) to discover how your team can better meet the high expectations of physicians at the frontline.

This report compares the current activities of medical affairs teams for the six leading CLL treatments from Novartis, Gilead, Roche, Janssen, AbbVie and Genmab. It shows:

How physicians rate each team overall, and for 12 key medical affairs services.
What is most important to physicians, plus what can be done better.
How, and how often physicians want to meet with your team.

It’s time to find out exactly how well your medical affairs team is performing against fierce competition – and establish an action plan to gain competitive advantage

Interested in the US market? Click here to see US Edition.

Top Takeaways

Stand out or forgettable? One team strides ahead with 94% of physicians recalling an interaction within the last 6 months. For many, a monthly visit is preferable.
Building confidence: How much do European physicians rely on medical affairs to answer questions about off-label usage? What are they spending more time talking about to medical affairs professionals than ever before?
Fierce competition: One team tops the satisfaction table for every single medical affairs attribute. Which teams are closing in fast and where are they making the most impact?
Pleased to see you: Face-to-face meetings are liked but are they the most preferred form of interaction? How do medical meetings and education events compare?
Good news for all: Physicians praised every drug for at least 3 areas of support provided by medical affairs.
Information is king: : 39% of respondents want to know more from their medical affairs teams. What specifically are they asking for?

Insight into Medical Affairs Teams for These CLL Brands

Arzerra (ofatumumab; Novartis/Genmab)
Gazyvaro (obinutuzumab; Roche)
Imbruvica (ibrutinib; Janssen)
MabThera (rituximab; Roche)
Venclyxto (venetoclax; Roche/AbbVie)
Zydelig (idelalisib; Gilead)

An Expert-designed Competitive View of Your Medical Affairs Team

Developed with the help of medical affairs specialists, this report gives you an in-depth comparison of 7 medical affairs teams—answering important questions like:

What do physicians need?

How, and how often are they using your medical affairs team?
What services do they consider most important?
How often should you contact them? What channels are best?

Does your medical affairs team deliver?

How memorable are your team’s interactions with doctors?
How do doctors rank your team for performance and satisfaction in 12 key areas?
How does your team compare to the competition—in each area, and overall?

What needs improvement?

Are you delivering the services that are most important to doctors?
Where do you need to improve?
How can your team enhance its services?

Based on Interviews with Practicing Doctors

We surveyed 150 medical oncologists and haematologists from the EU5 (France, Italy, Germany, Spain, UK)—chosen from the largest community of validated physicians in the world.

All respondents:

Have been practicing for between 3 and 35 years
See at least 5 patients with CLL in a typical month
Devote at least 50% of their time to direct patient care
Have interacted with at least one listed product’s medical affairs team in the past 6 months.

1. Objectives, Survey Methodology and Sampling, Products Included in the Survey, Executive Summary
2. Current Status of Interactions with Different Medical Affairs Teams
3. Interactions in the past 6 months with Medical Affairs teams for each product
4. Current frequency of interactions with medical affair teams for each product
5. Competitive Evaluation of Medical Affairs Teams Performance on Various Attributes
6. Evaluation of overall quality of interactions with Medical Affairs teams for each product
7. Attribute importance of Medical Affairs teams roles to physicians’ practice
8. EdgeMap analysis – Competitive evaluation on Medical Affairs teams performance on attributes
9. Competitive evaluation of physicians satisfaction of interaction with Medical Affairs teams
10. Need-Gap analysis by product
11. Preferred Interaction Media, Frequency, and Suggestions for Improvement
12. Preferred interaction media and frequency, and suggestions for improvement
13. Appendix

Aethlon Medical Inc (AEMD) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and

USD 250View Report

American CryoStem Corp (CRYO) - Medical Equipment - Deals and Alliances Profile

American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived

USD 250View Report

Medical Affairs in Emerging Markets

How can medical affairs capability be enhanced to unlock the Brazilian, Russian, Indian and Chinese pharma marketsThe pharma markets of Brazil, Russia, India and China (BRIC) are becoming increasingly complex

USD 2495View Report

Medical Affairs Reputations: Renal Cell Carcinoma (EU5) 2018

In the EU5, several of the renal cell carcinoma (RCC) medical affairs teams we surveyed are running neck and neck with at least one rival. The 150 medical oncologists we

USD 6365View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


  • PDF    USD 6175
  • Enterprise Wide Licence    USD 9275
$ 6175

Reports Details

Published Date : Aug 2017
Country :Global
Category :Healthcare
Publisher :FirstWord Dossier
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE


We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube